Page 7 - Accustem Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accustem sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accustem Sciences Today - Breaking & Trending Today

Tiziana Life Sciences : Distribution Dates for shares and ADRs in Accustem Sciences Limited (Form 6-K)

Tiziana Life Sciences : Distribution Dates for shares and ADRs in Accustem Sciences Limited (Form 6-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New York , United States , United Kingdom , City Of , Tiziana Adss , Gabriele Cerrone , London Stock Exchange , Tiziana Life Sciences , Jp Morgan , Redchip Companies Inc , Adrs In Accustem Sciences , Accustem Sciences , Distribution Dates , Accustem Sciences Limited , Life Sciences , Record Time , Accustem Shares , Action Type , Off Issuer Name , Withholding Rate , Cancellation Books , Spin Off Distribution , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் ,

Tiziana Life Sciences Plc: Tiziana Life Sciences plc Announces Plans to List Accustem Sciences Limited in the U.S.

(0)
NEW YORK and LONDON, April 13, 2021 (GLOBE NEWSWIRE) Tiziana Life Sciences plc (NASDAQ:TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited ( Accustem ), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders.
The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustem s business.
About Accustem Sciences
StemPrintER is a multi-gene prognostic assay intended to predict the risk of recurrence of R+/HER2- breast cancer, and Spare, a derivative of StemPrintER, combines StemPrintER with two clinical markers. This gives a more refined risk model. ....

United States , United Kingdom , City Of , Gabriele Cerrone , Tiziana Life Sciences Plc Adr Aktie , Accustem To Tiziana Life Sciences , American Society Of Clinical Oncology , Accustem Sciences Limited , Tiziana Life Sciences , Redchip Companies Inc , Accustem Sciences , Life Sciences , Nasdaq Stock Market , American Society , Clinical Oncology , Virtual Conference , Kingdom Investors , Relations Contact , Chip Companies , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , கேப்ரியல் சிஇஆர்ஆர்ஓஎன்இ , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , வாழ்க்கை அறிவியல் , நாஸ்டாக் ஸ்டாக் சந்தை ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Innovent Biologics , Karim Mikhail , John Thero , Eli Lilly , Gain Therapeutics Inc , Systems Inc , Auris Medical Holding Ltd , Celcuity Inc , Mimedx Group Inc , Centers For Disease , Life Sciences Corp , Drug Administration , Tiziana Life Sciences , Amarin Corporation , Liquidia Corporation , Burning Rock Biotech Limited , Fortress Biotech Inc , Accustem Sciences , Roche Holding , Biotech Stocks Hitting , Highs April , Medical Systems , Medx Group , Lows April , Disease Control , For Self Injectable ,

Investegate |OKYO Pharma Limited Announcements | OKYO Pharma Limited: Directorate Change

7 January 2021
OKYO Pharma Limited ( OKYO or the Company ) today announces that Gabriele Cerrone has been appointed as a non-executive chairman of the company and Dr Gary S. Jacob has been appointed as Chief Executive Officer and director of the company, both with immediate effect.
Gabriele Cerrone (age: 48)
Mr Cerrone has a successful track record and extensive experience in the financing and restructuring of micro-cap biotechnology companies. He has founded ten biotechnology companies in oncology, infectious diseases and molecular diagnostics, and has taken seven of these companies to the NASDAQ Market and two to the Main Market and AIM Market in London. Mr Cerrone is Executive Chairman of dual listed Tiziana Life Sciences plc. Mr Cerrone co-founded Cardiff Oncology, Inc. (NASDAQ: CRDF), an oncology company and served as its Co-Chairman; he was a co-founder and served as Chairman of both Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) and Callisto Ph ....

United States , United Kingdom , City Of , Robert Emmet , Gabriele Cerrone , Garys Jacob , Willy Simon , Monsanto Gd Searle , Siga Technologies Inc , Founder Of Hepion Pharmaceuticals Inc , Pharma Limited , Founder Of Tiziana Life Sciences , Synergy Pharmaceuticals , Bausch Health Inc , University Of Missouri , Optiva Securities , Board Of Hepion Pharmaceuticals Inc , Callisto Pharmaceuticals Inc , Bristol Myers Squibb Co , Synergy Pharmaceuticals Inc , Cardiff Oncology Inc , Immuron Inc , London Stock Exchange , Fermavir Pharmaceuticals Inc , Board Of Directors Cardiff Oncology Inc , Remuneration Committee ,